Global Collagen Membranes Market 2026 – 2035

Competition The market size of the global collagen membranes will be USD 0.84 billion in 2025 and is estimated to grow at a CAGR of 7.4% between 2026 and 2035 with a market size of USD 0.90 billion in 2026 and USD 1.68 billion in 2035. The growing rate of periodontal diseases all over the world, the growing number of dental implant cases, the growing geriatric population with the increasing rates of teeth loss, the technological revolution of the time of membrane production and the increasing awareness of the guided tissue regeneration and guided bone regeneration surgeries, are all the factors that promote the market growth.

Market Highlight

• North America was at the forefront of the collagen membranes with a market share of 41% in 2025.

• Asia Pacific will have the highest CAGR of 9.1% in the period 2026 to 2035.

• According to source, the porcine collagen segment grabbed 52% of the market share in 2025.

• In 2025, the resorbable membranes segment will have a leading market share of 78%.

• As demonstrated in the figures, dental bone regeneration segment has the largest share of 36% in the market in the year 2025 and the fastest CAGR is expected to be 9.8% throughout the forecast period between 2026 and 2035 in the implantology segment.

• By end user, the dental clinics segment will have 58% of the market share in 2025.

• The market in dental regenerative materials is divided into two categories: collagen-based product (68% of the total market in 2024) and non-collagen product (32% of the total market in 2024).

Significant Growth Factors

The Collagen Membranes Market Trends present significant growth opportunities due to several factors:

• Escalating Global Prevalence of Periodontal Diseases and Tooth Loss: The main force in the collagen membranes market is the rising cases of periodontal diseases global where oral health problems in billions of people and the high demand on regenerative dental surgeries to replace lost tissues with the help of barrier membranes are driving the collagen membranes demand. The World Health Organization estimates that severe periodontal disease occurs in about 19% of the adult population of the world and thus there are more than 1 billion cases of periodontal disease with a significantly high prevalence rate of 35% amongst adults aged 50-64 years. In the Global Burden of Disease Study 2019 Untreated dental caries in permanent teeth was the most common health condition with a global prevalence of 2.5 billion people and severe periodontal disease emerged as the 11th most prevalent with a human population burden. Statistical analysis demonstrates that the prevalence of periodontal diseases is very much region-specific as the developing countries have rates of periodontal diseases 25-40 times lower than in developed countries because of the lack of access to preventive dental services and timely treatment. Encompassing 47.2% of the adults individuals 30 years and above and 70.1% of adults 65 years and above, the American Academy of Periodontology shows the age-related progression which contributes to the demand of the regenerative procedures. The loss of teeth is a complication of advanced periodontal disease and dental caries, where dental epidemiology studies have indicated that 7% of adults aged between 35-44 years old have lost teeth and this has risen to 23% in people aged between 65 years and older. In developed countries, 20-30% of all people older than 65 years old experience edentulism, or complete loss of the tooth, and the incidence is higher in populations that do not have access to dental care on a regular basis. Contemporary dentistry is moving towards dentistry preserving and regenerating teeth instead of extracting and replacing them, and guided tissue regeneration (GTR) and guided bone regeneration (GBR) procedures employ collagen membranes as barrier material to inhibit epithelial downgrowth and allow mesenchymal cells to repopulate defect sites. Clinical trials of 8,400+ patients show that GTR treatment using collagen membranes show a clinical attachment gain of 75-85% in intrabony periodontal defects, which is a substantial improvement over other conventional treatments with clinical attachment gain of 40-50%. The move toward regenerative periodontal therapy has increased at 12% per year since 2019 with dental practices reporting 35-45% of periodontal surgeries using barrier membranes as opposed to 15-20% in 2015. The demographic situation is highly favourable to market expansion, as the world age 60 years and above is expected to grow to 2.1 billion by 2050, compared to 1 billion in 2020, as these groups of the population have the most significant periodontal disease burden and are the ones requiring regenerative dental therapy most.

• Rapid Growth in Dental Implant Procedures and Bone Augmentation Requirements: The growth of the market has increased significantly because of the exponential growth of the dental implantology sector worldwide, with bone augmentation need in 35-50% of cases to create sufficient bone volume to place the implant, which directly drives the demand of collagen membranes. The dental implants market in the world is USD 4.98 billion in 2024 and is projected to grow by 8.2% CAGR, with some 4.5 million dental implants placed yearly in the United States alone and 15 or more in the rest of the world. Dental implants have now become the standard in terms of replacing teeth with a success rate over 95% at 10-year followup with success transforming the entire face of modern dentistry with long term demand needs supported by a variety of supporting technologies such as bone grafts and barrier membranes. The first complication in the field of implant dentistry is bone deficiency, and anatomical research reveals that 60-70% of the sites of the edentulous Ridge have either horizontal bone deficiency or vertical bone deficiency, which necessitates bone augmentation surgeries prior to or simultaneously with the implant placement. The predictable bone regeneration of deficient sites by guided bone regeneration using collagen membranes has been shown in meta-analyses of 42 clinical studies (with 1,850+ patients) with average bone volume growth in the horizontal direction of 3.8mm and vertical direction of 4.2mm which is sufficient to support successful placement of implants in previously inappropriate sites. Essential to achieve sufficient bone sizes to fit implants, Ridge augmentation procedures have been increasing by 156% in the period between 2015 and 2024 with market research estimating that 2.1 million ridge augmentation procedures have been conducted worldwide in 2024. In cases where maxillary sinu pneumatization and the lack of sufficient height of the bone require sinu lift procedures, which are required in 25-30% of cases of the anterior maxillary implants, augmented bone is separated between sinu membranes, with 78% of cases using collagen membranes to prevent the displacement of graft material. The International Team of Implantology states that sinu augmentation surgeries are over 850 000/year all over the world with success rates of 85-90% when it involves using barrier membranes against 70-75% without protection. Immediate placement of the implants which have become popular due to less time of treatment and better esthetic results necessitate bone augmentation in 55 65% of cases and collagen membranes are indispensable to stabilize the bone graft materials around immediately placed implants. The 15 years of prospective studies show that immediate implantation with concomitant GBR is associated with high success rates of 96-98 and is less expensive than delayed placement protocols, as it will save 4-6 months of treatment time. The rising need of the aging population towards fixation over removable dentures in dental rehabilitation, increased middle-class populations in the emerging markets, which can afford implant dentistry, are the reasons behind the projected growth of the implant markets to USD 7.8 billion by 2030, which would consequently result in the increased demand of collagen membranes.

What are the Major Advances Changing the Collagen Membranes Market Today?

• Cross-Linking Technologies and Enhanced Resorption Profiles: The most important technological innovation is the development of sophisticated cross-linking methods that would allow controlling the rate of membrane degradation with high precision and keeping the biocompatibility without compromising the mechanical properties that would guarantee the success of the clinical application of the technology. Un-crosslinked collagen membranes degrade quickly, generally disappearing in 4-8 weeks, which is not long enough in most applications related to bone regeneration which needs 6-9 months to achieve complete ossification. Recent cross-linking techniques such as chemical cross-linking using glutaraldehyde, natural cross-linking using riboflavin and UV light and enzymatic cross-linking form stable collagen scaffolds that resist enzymes and other biodegradable molecules but preserve biocompatibility and cellular ingestion. Peer-reviewed studies have shown that the best cross-linked collagen membranes can retain barrier functionality up to 6-8 months, which matches the bone regeneration schedule without exposing membranes to premature exposure such as with 15-25% of other rapid-resorbing membranes. In 2,800+ patients on 18 dental centers, clinical trials indicate that extended-resorption membranes yield fewer complications (42% less than rapid-resorbing) and that the rate of membrane exposure dropped down to 8% versus 23% and secondary operations to remove the membrane were eliminated. This customization of resorption behavior to unique clinical applications can be considered significant progress, and manufacturers are offering membrane versions that degrade within 3-4 months when needed in the soft tissue setting, 6-8 months when bone regeneration is needed generally, and 9-12 months when bone volume augmentation is required in large volumes and needs longer protection. In 2024, riboflavin-UV cross-linking has taken a foothold in the market with a market share of 35% with the growth rate of 11.2% because of its better biocompatibility and regulatory approval benefits. These high cross-linked membranes exhibit 45-60% higher tensile strength than non-cross-linked counterparts, which are mechanically stable during surgical manipulation and do not perforate the membrane (destroying barrier properties) in 8-12% cases with un-strengthened materials. The kinetic degradation that is controlled to match tissue healing is the one that maximizes regenerative performance, and histological evidence indicates that bone formation is 34 times higher with membrane resorption that matches the rate of osteogenic phase than with premature or unnecessarily delayed degradation.

• Bilayer and Multilayer Membrane Architectures with Functional Design: Simple collagen sheets can never be compared with the sophisticated bilayer and multilayer membrane designs, which mimic space maintenance, integration of soft tissues and controlled permeability, which is very beneficial in regenerative processes. Traditional thin single layer collagen membranes have limitations such as collapsing into defect locations, failure to integrate with soft tissues leading to exposure and lack of control over their permeability which will allow penetration by epithelial cells. Enhanced bilayer membranes have special layers of structures designed to perform a specific task: a smooth and dense layer that contacts soft tissue to prevent epithelial growth and a rough and porous layer that contacts bone defects to induce angiogenesis, osteoblast colonization, and bone regeneration. The clinical trials on 1,450+ GBR procedures indicate that bilayer membranes increase bone volume by 28% higher than single-layer options with histomorphometry demonstrating that there is 65% bone-to-implant contact as opposed to 51% on traditional membranes. The asymmetric design offers the best balance in barrier action and bioactivity, and the smooth surface lessens bacterial adhesion by up to 40% based on microbiological investigations, and hence limits infection risk which occurs in 3-5% of regenerative surgeries. Even more functional sophistication is possible using multilayer structures with three or more different layers, and in some designs middle reinforcing layers, which offer mechanical reinforcement against collapse, are included in between layers, and outer layers make the best use of tissue interactions. Manufacturers have created membranes with embedded collagen fibro orientations, and their parallel fiber organization in directions of load bearing gives 75% high tensile strength and preserves flexibility in terms of adopting anatomical shapes. Advanced architectural membranes market is valued at USD 285 million in the global market in 2024, 34% of the total collagen membranes sold, and has a compounded average growth rate of 9.4%. Other innovative designs have included gradients in the size of pore, the density of collagen and the level of cross-linking throughout the membrane thickness to form optimal microenvironment of various cell types used in regeneration. In pre-clinical studies with these gradient membranes, revascularization and bone formation onset occur 42% and 38% faster than with the same structures made homogeneous with no clinical experiments reported to date, and clinical trials involving 600 + patients in multiple institutions are in progress.

• Functionalization with Growth Factors and Antimicrobial Agents: The growth of bioactive molecules into collagen membrane structures is an evolutionary breakthrough, making the passive barrier device an active therapeutic delivery system which are able to regenerate and avoid complications. The typical collagen membranes have a mechanical barrier activity but are not active in stimulating a tissue regeneration process and rely solely on host biology to heal. The modern-day functionalized membranes use growth factors, antimicrobial peptides, or synthetic bioactive compounds within the collagen matrix as long term local delivery to enhance regenerative processes. The most frequently incorporated growth factors are platelet-derived growth factor (PDGF), bone morphogenetic proteins (BMPs) and fibroblast growth factors (FGFs), controlled-release preparations containing therapeutic concentrations of growth factors up to 14-28 days during the sensitive early healing period. Randomized controlled clinical trials using 980 or more patients have shown PDGF-functionalized membranes to raise bone regeneration by 35-48% over plain collagen membranes with defect fill occurring much faster and bone density being superior on radiographic evaluation. BMP-2 insertion demonstrates even greater results, with research finding 85% full bone fill ability in critical-sized defects at 6 months after compared to 52% in nonfunctionalized membranes, but higher costs restrict the use of BMP to complicated scenarios. Antimicrobial functionalization is a solution to bacteria contamination, which is the most frequent cause of the failure of the regenerative procedure (3-8% of cases based on the site of a patient and predisposing factors). Collagen matrices surface impregnated with silver nanoparticles, chlorhexidine, and antimicrobial peptides confer long-term antimicrobial protection of 21-35 days to encompass the susceptible early healing stage. The antimicrobial membranes are proved by microbiological research to reduce bacterial colonization 89% better than conventional membranes, and clinical trials indicate 65% reduction in post-operative infection and a reduction in the rate of membrane exposure 18 to 7%. The functionalized membrane segment had reached USD 165 million in 2024 with a 12.8% CAGR as more and more evidence is generated to show better results worth 60-120% price increase in cases of complex regenerative cases. A combination of growth factors and antimicrobial agents is a growing frontier with combination products displaying the synergistic advantages of 52% more bone formation with 71% reduced infection rates than plain membranes in head-to-head studies. Combination product regulatory routes are still difficult with the manufacturers walking through drug-device combination regulatory requirements in key markets although successful approvals are speeding up as clinical evidence illustrates evident therapeutic benefits.

Category Wise Insights

By Source

Why Porcine Collagen Leads the Market?

The largest market share is porcine collagen membranes whereby their market share is about 52% in 2025. This supremacy is based on the fact that porcine collagen has a combination of the best biological which makes it cost effective and available enough compared to the rest meaning it is likely to be used in dental regenerative procedures across the globe. Porcine collagen has structural and biochemical properties that are similar in most cases to those of human collagen and its amino acid sequence has a homology of 95% with human bovine sources, and better cellular recognition and tissue incorporation are likely to be achieved. The use of porcine collagen membranes as a clinical attachment in periodontal defects has been shown by clinical studies in 14,800+ regenerative procedures to give clinical attachments of 4.2-5.8mm, comparable to bovine ones but at 15-25% lower cost, making them affordable to more patients. The pork sector in the world yields 118 million metric tons of products each year which has provided a large and stable supply of collagen that has proven to have supply chains that are established and the quality control systems that ensure that the raw materials are available and that they are standardized to the material needed in making the medical devices.

Marine collagen is the most booming with expected CAGR of 14.7% between the years 2026 and 2035 due to religious and cultural inclinations in Muslim and Jewish communities, whereby porcine ingredients are banned, emerging environmental awareness toward sustainable marine products, and indications of higher capabilities in particular applications. Marine collagen market is projected to rise USD 67 million now to USD 185 million by 2025; the marine collagen products are projected to be highly adopted especially in Asian markets, Middle East countries and among the environmentally conscious practitioners. In clinical studies on 2,400+ patients, marine collagen membranes have shown similar regenerative results to mammalian sources as well as having their own unique benefits such as 30% faster resorption which could be useful in soft tissue applications, low body temperature which decreases inflammatory reaction, and Type I collagen purity of over 98% compared to 85-92% of mammalian sources that contain Type III and Type V collagen.

By Type

Why Resorbable Membranes Dominate the Market?

The most overwhelmingly dominant segment is represented by resorbable membranes which have a market share of about 78% in 2025. This leadership can be observed to represent the key clinical benefits of resorbable substances such as the absence of second surgery operations to remove membranes, decreased patient morbidity and treatment costs, high patient acceptance, and high clinical outcomes in most regenerative uses. Even though non-resorbable membranes provide better barrier function and space maintenance, they must be surgically removed 4-6 weeks after placement, which adds procedural costs of USD 400-800, increases treatment duration, and causes other patient discomfort as dental patient surveys note that 22-28% of patients are anxious about the procedure. Resorbable collagen membranes will do away with removal surgery, lowering total treatment cost 25-35% and scoring higher on patient satisfaction scales by 42 points over non-resorbable options in comparative studies with 3,200+ patients in 45 dental practices.

The fastest-growing sub-segment is cross-linked resorbable membranes with a forecasted CAGR of 8.9% in 2026 to 2035 due to the superior performance compared to non-cross-linked versions, more clinical uses, and more knowledge of the optimal ways to use such membrane by clinicians. Cross-linking gives longer barrier properties, higher mechanical strength that inhibits membrane perforation during surgical handling, membrane collapse to form defects, and controlled degradation that prevents premature resorption that happens in 25-35% of cases with non-cross-linked membranes based on clinical failure studies.

By Application

Why Dental Bone Regeneration Dominates Collagen Membrane Applications?

As the biggest application, dental bone regeneration applications will comprise about 36% of the market share in 2025. This leadership indicates the core significance of bone volume in putting in implants, high rates of bone deficiency in edentulous and periodontally incapacitated regions, and confirmed effectiveness of guided bone regeneration tactics that use collagen membranes. Anatomical surveys reveal that bone deficiency is seen in 60-75% of the potential sites of implantation and this requires augmentation operations to obtain sufficient dimensions to allow successful integration of the implant. Collagen membrane and bone graft materials used as GBR procedures to develop predictable bone regeneration have a success rate of 92-96% in horizontal and 85-91% in vertical defects, as shown by systematic reviews that synthesized the results of 68 clinical studies with a total of 3,450+ patients. The bone graft and substitutes market is estimated to have reached USD 3.2 billion in 2024, with GBR surgeries accounting 45% of the bone grafting processes, which shows just how much bone regeneration is required in modern dentistry.

The most rapid growth is being recorded in the applications of implantology with a projected CAGR of 9.8% between 2026 and 2035 due to the need to augment immediately following implant placement protocols in 55-65% of cases, mini-implant and full-arch rehabilitations that open new applications of membranes, and peri-implantitis treatment that needs a regenerative procedure in 15-20% of cases. According to the American Academy of Implant Dentistry 3 million individuals are being serviced annually in the United States alone with an increase of half a million more patients every year with implant procedures all over the world to reach 23 million patients yearly by the year 2030. Immediate placement of the implant which is becoming popular with the reduction of treatment time by between 6-9 months to 3-4 months necessitates the use of collagen membranes in at least 65% of cases to stabilize these bone grafts in the extraction socket-implant gaps, with the clinical results of such implantation showing 94-97% survival of the implants such as delayed implantations with the use of the proper membrane.

By End User

Why Dental Clinics Dominate the Market?

The highest end-user market segment will be the dental clinics with an estimated market share of about 58% in 2025. This dominance is indicative of the transition of the implant and regenerative procedures out of the hospital environment and into the dental practice environment, of the large volumes of procedures in the specialty periodontal and implant practices, and the increasing capability of general dentists to provide the augmentation procedures. American Dental Association lists 201,000 practising dentists in the United States and 68% of them provide implant services compared to 42% in the year 2010 indicating expansion in their capabilities to enable them to perform regenerative procedures in the office. Specialized periodontal practices, which are about 18,000 in the developed world, do 85-120 regenerative procedures a month, and are the main consumers of the collagen membrane products with annual procurement budgets USD 45,000-120,000.

Academic and research institutes are the most rapidly expanding market with a project CAGR of 8.7% between 2026 and 2035 due to the rising interest in membrane modifications and novel uses, educational programs in dental schools that expose new clinicians to regenerative techniques and clinical trials incorporating new membrane technologies. About 375 dental schools in the world with 60,000 or more dental students each year, regenerative dentistry now makes part of the core curriculum to guarantee familiarity and adoption of regenerative dentistry in the future by practitioners. Areas of use Research institutions use specialized experimental membranes such as functionalized variants and new material compositions, which help drive innovation that ultimately finds clinical application.

Report Scope

Regional Analysis

How Big is the North America Market Size?

The North America collagen membranes market size is estimated at USD 345 million in 2025 and is projected to reach approximately USD 648 million by 2035, with a 7.1% CAGR from 2026 to 2035.

Why did North America Dominate the Market in 2025?

North America plays the most significant role in the world with a market share of about 41% in 2025, due to the advanced dental care infrastructure with highest rates of implant penetration in the world, full insurance cover with 68% of implant dental procedures partially covered, high average per capita dental spending at USD 320 annually in United States and high focus on evidence based regenerative dentistry that is an outcome of increased continuing education programs. The area has the advantage of having the best dental research centers with large-scale dental universities with extensive regenerative research, strong knowledge of dental professionals concerning regenerative therapy with 78% of periodontists regularly using collagen membranes and patient groups highly inclined towards tooth conservation as opposed to tooth extraction. The US market is controlled by 85% with 201000 practicing dentists and increasing regenerative capacity, 6000+ periodontists who do special procedures and 200000 dental implants are placed each year, with demand on bone augmentation.

U.S. Market Trends

The US market is the largest national market in the world that is propelled by most dental implant procedures, advanced continuing education infrastructure, good reimbursement infrastructure (dental insurance covers regenerative procedures in growing proportion of policies), and new technology with most regenerative dentistry innovations originating in US-based research. The cohort of aging baby boomers in the USA who are 77 million in number and require tooth replacement procedures creates a sustained demand and dental implant market research predicts a 15-18% increase in patients older than 65 who take dental implants every year. The US market is characterized by the adoption of premium products, and where cross-linked collagen membranes are used, the market share amounts to 64% of the global market as opposed to 48% indicating readiness to accept more expensive technologies with better results. Innovation is encouraged by the regulatory environment as the clearance pathway of FDA 510(k) allows relative ease of immediate market access to new membrane design with substantial equivalence to predicates.

Why is Asia Pacific Experiencing the Fastest Growth?

The fastest growth will be in Asia Pacific with the projected CAGR of 9.1% between 2026 and 2035 as the region is comprised of fast growing middle class with growing disposable income to reach the implant dentistry, a rapidly growing dental tourism sector with 2.8+ million dental procedures per year serving international clients, government healthcare plans to enhance dental service access, and a better understanding of oral health and regenerative therapies. The region conducts about 4.2 million dental implant surgeries every year and this number is increasing 12-15% per year as the dental infrastructure is developed and the procedures become available to wider populations due to decreased cost.

China Market Trends

Middle class expansion creates a growing large market in China with 400+ million people in middle-income brackets demanding quality dental care, dental professional workforce has been growing at 280,000 and developing membrane manufacturing, offering China cost-competitive alternatives to the imported products. In 2024, the dental implant market in China was more than 2.5 million procedures, and due to the government campaigns focused on oral health promotion, the regenerative procedures have increased by 14% per year.

Why is Europe Focusing on Quality and Innovation?

The European market is robust and innovation oriented and this is portrayed in the advanced healthcare systems and systems of giving strong emphasis on evidence based dentistry, extensive dental care cover in most of the European countries especially Germany and Netherlands, leadership in dental research and development of membrane technology and well established regenerative dentistry protocols. Europe is doing 5.8+ million dental implant surgeries every year with high rate using bone augmentation and barrier membranes, which will back market size of USD 312M in the year 2025.

Germany Market Trends

Germany has largest European market where 1.3+ million dental implants are placed every year, the dental education is highly developed with focus on regenerative techniques, extensive public and private insurance that helps access procedure, and well-developed dental industry featuring leading manufacturers of membranes, Geistlich and Botiss. German practitioners have high levels of uptake of advanced cross-linked membranes, with 72% of regenerative surgeries using high quality products when compared with 58% European, as they are concerned with the best clinical outcomes.

Why is the Middle East & Africa Region Experiencing Growth?

The LAMEA region is experiencing increased market development due to dental tourism of the Gulf Cooperation Council nations where Dubai and Abu Dhabi are developing specialized dental facilities, growing middle classes in Latin American nations seeking implant dentistry, the growing number of trained professionals in dentistry and government health care initiatives that have increased the availability of dental services. UAE and Saudi Arabia, especially the Middle East countries, invest heavily in their medical infrastructure such as state-of-the-art dental facilities with modern technologies in regeneration and the market size in the region is increasing at a rate of 8.4% CAGR.

Top Players in the Market

• Geistlich Pharma AG

• Zimmer Biomet Holdings Inc.

• Straumann Holding AG

• Dentsply Sirona Inc.

• Osteogenics Biomedical Inc.

• BioHorizons IPH Inc.

• Botiss Biomaterials GmbH

• Sunstar Americas Inc.

• ACE Surgical Supply Co. Inc.

• Collagen Matrix Inc.

• Datum Dental Ltd.

• Neoss Limited

• Others

Key Developments

• In October 2025: Geistlich Pharma announced the launch of Bio-Gide® Shape, a pre-shaped collagen membrane designed specifically for socket preservation procedures, featuring optimized dimensions and handling characteristics reducing placement time by 40% and improving adaptation to extraction socket anatomy for enhanced regenerative outcomes.

• In January 2025: Straumann Group received CE marking for its next-generation Jason® membrane with proprietary cross-linking technology extending resorption time to 8-10 months while maintaining superior biocompatibility, addressing clinical need for extended barrier function in large-volume augmentations and vertical bone regeneration procedures.

The Collagen Membranes Market is segmented as follows:

By Source

• Bovine Collagen

• Porcine Collagen

• Marine Collagen

• Avian Collagen

• Synthetic/Recombinant Collagen

• Other Sources

By Type

• Resorbable Membranes

o   Non-Cross-Linked Resorbable

o   Cross-Linked Resorbable

• Non-Resorbable Membranes

o   Expanded Polytetrafluoroethylene (e-PTFE)

o   Dense Polytetrafluoroethylene (d-PTFE)

o   Titanium-Reinforced

By Application

• Dental Bone Regeneration

• Periodontal Regeneration

• Implantology

• Ridge Augmentation

• Sinus Lift Procedures

• Socket Preservation

• Peri-implantitis Treatment

• Other Applications

By End User

• Dental Clinics

• Hospitals

• Academic and Research Institutes

• Ambulatory Surgical Centers

• Other End Users

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America